GreenLight Biosciences lands $102m
Boston-based GreenLight Biosciences Inc, a developer of RNA-based solutions for agriculture and pharmaceutical applications, has raised $102 million in funding.
Boston-based GreenLight Biosciences Inc, a developer of RNA-based solutions for agriculture and pharmaceutical applications, has raised $102 million in funding.
Copyright PEI Media
Not for publication, email or dissemination